Sick and almost tired about Twitter? Already 11 years… #IlMioAnniversarioDiTwitter
Latest posts 5
AZIMUTH is our new solution to help patients suffering from heart failure: a new model of care co-designed and co-developed by doctors, patients, industrial and technological partners! linkedin.com/posts/domenico…
www.linkedin.com AZIMUTH is our new solution to help patients suffering from heart failure: a new model of care... AZIMUTH is our new solution to help patients suffering from heart failure: a new model of care co-designed and co-developed by doctors, patients, industrial and technological partners! Fondazione... I was very pleased to present the result of the VECTOR-HF trial during the late breaking clinical session #LBCT at HFA-ESC meeting in Madrid! #HeartFailure2022 Thank to all the investigators. @escardio @VectoriousTech @_antocannata @BURZOTTA_F @HFA_President @WilfriedMullens
Proud to share our latest manuscript: Association Between Dosing And Combination Use Of Medications And Outcomes In Heart Failure With Reduced Ejection Fraction: Data From The Swedish Heart Failure Registry!
Have a look! onlinelibrary.wiley.com/doi/abs/10.100…
Have a look! onlinelibrary.wiley.com/doi/abs/10.100…
onlinelibrary.wiley.com Association between dosing and combination use of medications and outcomes in heart failure with... In heart failure with reduced ejection fraction (HFrEF) lower doses of multiple drugs are associated with better outcome compared to one pharmacological class at optimal target dose (TD). ACEi,... “We all know that first kiss is destiny knocking!” Proud to have enrolled the first patient of the KISS study at our site.. @PoliclinicoGemelli @Unicatt @BURZOTTA_F @RoccoVergallo @enromagnoli @CristinaAuri17 @carlotrani